One platform for all researcher needs
AI-powered academic writing assistant
Your #1 AI companion for literature search
AI tool for graphics, illustrations, and artwork
Unlock unlimited use of all AI tools with the Editage All Access membership.
Explore Editage All Accesshttps://doi.org/10.1182/blood.v124.21.713.713
Copy DOI Journal: Blood |  Publication Date: Dec 6, 2014 |
 Citations: 33 |
Affiliation: The University of Texas MD Anderson Cancer Center, Mayo Clinic, St. Paul's Hospital, Princess Margaret Cancer Centre, Icahn School of Medicine at Mount Sinai, Presbyterian Hospital, New York Hospital Queens, NewYork–Presbyterian Hospital, Cornell University, Brigham and Women's Hospital, Massachusetts General Hospital, Cancer Prevention Institute of California, Stanford UniversityPhase 2 Trial of PRM-151, an Anti-Fibrotic Agent, in Patients with Myelofibrosis: Stage 1 Results
Sign-in/Register to access full text options 
Free) Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
